Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Allos Therapeutics, Inc. (NASDAQ:ALTH.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ALTH.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

codergrrl (< 20)
Submitted January 07, 2008

Allos Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule therapeutics for the treatment of cancer.

Reply | Report this Post

Ruthie203 (59.62)
Submitted February 15, 2008

Wow, I just can't see it. With constant new management, directors, increased stock options, no viable product, living off investor money with promises that FDA might approve 2 bios, seems too risky for me. I might go it if not for the exit of 2… More

Reply | Report this Post

NASDAQ:ALTH.DL Summary

  • Sector:
    • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ALTH.DL.

No one has written a Pitch for ALTH.DL stock yet. Tell us why you think ALTH.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in ALTH.DL.

No players have picked ALTH.DL yet. Tell us why you think ALTH.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ALTH.DL.